Raymond J Dingledine (born December 17, 1948) is an American pharmacologist and neurobiologist who has made considerable contributions to the field of epilepsy.

[2] He then did postdoctoral stints with John Kelly and Leslie Iversen in Cambridge UK, and Per Andersen in Oslo Norway.

It was in Per’s lab, working with Leif Gjerstad and Iver Langmoen, that he developed a lifelong interest in epilepsy.

Shortly after a sabbatical year at the Salk Institute in Steve Heinemann’s lab, he joined Emory University in 1992 as Chair of the Department of Pharmacology, a job he held until 2017.

He served the Society for Neuroscience in numerous functions including Treasurer in 2003 and, most recently, as Chair of their Investment Committee for 15 years.

NeurOp Inc was founded in 2003 and is currently a clinical-stage company focused on developing NMDA receptor modulators for cerebral ischemia, pain and depression.